Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
At week 52 in PIONEER 10, the use of additional anti-diabetic use and rescue medication use was 6% to 18% and 2% to 17%, respectively, for patients in semaglutide treatment groups and 12% and 9%, respectively in the dulaglutide treatment group
Reported side effects Occasional mild injection-site reactions (redness, itching)
reports receiving research funding from a Novo Nordisk Investigator Sponsored Study
The cohort included 50 females and 15 males, ranging in age from 13 to 60 years, with disease duration between 1 to 15 years [40]
US$ 20.93
US$ 28.42
US$ 24.95
US$ 23.43
US$ 27.63
US$ 20.49
US$ 27.12
US$ 28.79
